Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.
Farapulse, a US-based medical device developer spun out of University of Iowa, has been acquired by its peer and existing shareholder Boston Scientific for a $295m upfront payment.
Boston Scientific currently owns a 27% stake in the spinout and will purchase all remaining shares. The corporate may pay out an additional $92m in milestone payments, as well as an undisclosed amount of revenue-based payments over the next three years.
Founded in 2014 as Iowa Approach, Farapulse is working…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.